Stay updated on Merck & Co. Press Releases
Sign up to get notified when there's something new on the Merck & Co. Press Releases page.

Latest updates to the Merck & Co. Press Releases page
- Check4 days agoChange DetectedThe webpage has added significant updates regarding Merck's new drug recommendations and research advancements, while also removing older trial results and drug announcements.SummaryDifference78%
- Check11 days agoChange DetectedThe page now includes information about the initiation of a Phase 3 trial for Ifinatamab Deruxtecan in prostate cancer patients, while the previous entry regarding the withdrawal of a biologics license application for Patritumab Deruxtecan has been removed.SummaryDifference84%
- Check18 days agoChange DetectedThe webpage has added significant updates regarding FDA approvals for various treatments and vaccines, including KEYTRUDA® for head and neck cancer and ENFLONSIA™ for RSV prevention in infants. Additionally, Merck's positive developments in clinical trials for new medications have been highlighted.SummaryDifference84%
- Check25 days agoChange DetectedThe page has added significant updates regarding Merck's participation in a major healthcare conference and new clinical trial results for KEYTRUDA, while it has removed previous announcements about FDA approvals and research presentations.SummaryDifference78%
- Check32 days agoChange DetectedThe page has been updated with significant announcements regarding Merck's investigational drugs and a dividend declaration, while several previous announcements about investments and conference participation have been removed.SummaryDifference81%
- Check40 days agoChange DetectedThe webpage has added significant updates regarding Merck's participation in upcoming conferences and the initiation of a new clinical trial, while removing previous announcements about financial results and a completed clinical trial.SummaryDifference78%
Stay in the know with updates to Merck & Co. Press Releases
Enter your email address, and we'll notify you when there's something new on the Merck & Co. Press Releases page.